March 1, 2026 · Form 4 insider transaction
Wambeke David J. bought 500,000 shares of NeuroOne Medical Technologies Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
25% will vest on March 1, 2027, and the remaining 75% will vest in 12 equal installments on the last day of each quarter beginning on March 31, 2027.